Scandinavian ChemoTech AB Series B Capital Reinvestment Ratio
Latest as of December 2020:
0.14x
Scandinavian ChemoTech AB Series B capital reinvestment ratio. Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Capital Reinvestment Ratio of 0.14x as of December 2020, meaning it reinvests 0% of its operating cash flow (Skr207.00K) in capital expenditures (Skr30.00K). Check CMOTEC-B cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.14x
Capex / Operating Cash Flow
Operating Cash Flow
Skr207.00K
SEK
Capital Expenditures
Skr30.00K
SEK
Data as of
Dec 2020
Most recent filing
Scandinavian ChemoTech AB Series B Capital Reinvestment Ratio by Year (None–None)
Scandinavian ChemoTech AB Series B capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see CMOTEC-B operating cash flow.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow